A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

Discover how benralizumab offers superior outcomes for eosinophilic asthma and COPD exacerbations, outperforming steroids in ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...